Diebold Nixdorf (DBD) Misses Q3 EPS by 17c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $67.08 -2.32%
Financial Fact:
Income (loss) from discontinued operations: 500K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Income (loss) from discontinued operations: 500K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q3 EPS of $0.34, $0.17 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $958.2 million versus the consensus estimate of $1.04 billion.
GUIDANCE:
Diebold Nixdorf sees FY2021 revenue of $3.9-3.95 billion, versus the consensus of $4.06 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts Lululemon (LULU) at Underperform
- BMO Capital Starts Abercrombie & Fitch (anf) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
